Ludwig Rasche

发表

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica

F. Paul, T. Niendorf, J. Wuerfel, 2019, Neurology: Neuroimmunology & Neuroinflammation.

MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study

F. Paul, T. Schmitz-Hübsch, J. Bellmann-Strobl, 2018, Front. Neurol..

Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study

F. Paul, J. Dörr, J. Wuerfel, 2016, PloS one.

Association Between Fatigue and Motor Exertion in Patients With Multiple Sclerosis—a Prospective Study

Martin Weygandt, Alexander U. Brandt, Friedemann Paul, 2020, Frontiers in Neurology.

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis

F. Paul, J. Wuerfel, J. Behrens, 2017, PloS one.

Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study

F. Paul, U. Reimer, J. Behrens, 2016, Journal of Neuroimmunology.

Association of serum Epstein–Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis

F. Paul, J. Behrens, J. Bellmann-Strobl, 2015, Journal of Neuroimmunology.

Ozanimod for the treatment of relapsing remitting multiple sclerosis

F. Paul, Ludwig Rasche, 2018, Expert opinion on pharmacotherapy.

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab

X. Montalban, F. Paul, D. Galimberti, 2020, Frontiers in Neurology.

Instrumental Assessment of Stepping in Place Captures Clinically Relevant Motor Symptoms of Parkinson’s Disease

Fabian Klostermann, Tobias Ellermeyer, Karen Otte, 2020, Sensors.

Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis

F. Paul, J. Behrens, J. Bellmann-Strobl, 2019, Neurology.

Low 25‐hydroxyvitamin D, but not the bioavailable fraction of 25‐hydroxyvitamin D, is a risk factor for multiple sclerosis

F. Paul, J. Dörr, J. Behrens, 2016, European journal of neurology.

Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis

F. Paul, J. Behrens, J. Bellmann-Strobl, 2015, Journal of Neuroinflammation.

Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis

F. Paul, J. Wuerfel, D. Meier, 2020, Multiple sclerosis journal - experimental, translational and clinical.

Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis

F. Paul, J. Behrens, J. Bellmann-Strobl, 2015, Journal of Neuroinflammation.

Translation and validation of the multiple sclerosis walking scale 12 for the German population – the MSWS-12/D

J. Bellmann-Strobl, I. Schiffmann, J. Stellmann, 2023, Health and Quality of Life Outcomes.